CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,782 | -96.3% | 10,108 | -95.9% | 0.00% | -96.0% |
| Q2 2023 | $7,962,770 | +100.7% | 244,107 | +116.5% | 0.02% | +78.6% |
| Q1 2023 | $3,968,236 | +16.8% | 112,766 | +30.4% | 0.01% | 0.0% |
| Q2 2022 | $3,398,000 | +75.3% | 86,473 | +64.2% | 0.01% | +100.0% |
| Q1 2022 | $1,938,000 | +2668.6% | 52,653 | +374.4% | 0.01% | – |
| Q4 2018 | $70,000 | -47.0% | 11,100 | -17.2% | 0.00% | – |
| Q3 2018 | $132,000 | -13.2% | 13,400 | -26.8% | 0.00% | -100.0% |
| Q2 2018 | $152,000 | -59.8% | 18,300 | -65.1% | 0.00% | -50.0% |
| Q1 2018 | $378,000 | – | 52,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |